Detail Information of Exogenous Modulation

General Information of Drug Transporter (DT)
DT ID DTD0001 Transporter Info
Gene Name ABCC1
Transporter Name Multidrug resistance-associated protein 1
Gene ID
4363
UniProt ID
P33527
Exogenous factors (drugs, dietary constituents, etc.) Modulation of This DT (EGM)

Approved Drug

  Glyburide

            3 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Glibenclamide inhibits the transportation of Calcein by ABCC1 [6]

Affected Drug/Substrate

 Calcein Modulation Type Inhibition

Cell System

 Human multidrug resistant lung cancer GLC4/ADR cells

  DT Modulation 2

 Glibenclamide inhibits the transportation of Antimony salts by ABCC1 [7]

Affected Drug/Substrate

 Antimony salts Modulation Type Inhibition

  DT Modulation 3

 Glibenclamide inhibits the activity of ABCC1 [6]

  Indomethacin

            3 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Indomethacin inhibits the transportation of 2',7'-Bis-(3-carboxy-propyl)-5-(and-6)-carboxyfluorescein (BCPCF) by ABCC1 (IC50 = 7 microM) [1]

Affected Drug/Substrate

 2',7'-Bis-(3-carboxy-propyl)-5-(and-6)-carboxyfluorescein (BCPCF) Modulation Type Inhibition

Cell System

 Human erythrocytes-MRP1

  DT Modulation 2

 Indomethacin inhibits the transportation of Doxorubicin by ABCC1 [10]

Affected Drug/Substrate

 Doxorubicin Modulation Type Inhibition

Cell System

 Human hepatocellular carcinoma cell line (HepG2)-MRP1

  DT Modulation 3

 Indomethacin inhibits the activity of ABCC1 [13] , [14]

  Cyclosporine

            3 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Cyclosporine inhibits the transportation of Leukotriene C4 by ABCC1 (Ki = 5 microM) [4]

Affected Drug/Substrate

 Leukotriene C4 Modulation Type Inhibition

Cell System

 Human cervical cancer cell line (Hela)-MRP1

  DT Modulation 2

 Cyclosporine inhibits the transportation of Leukotriene C4 by ABCC1 (IC50 = 5 microM) [4]

Affected Drug/Substrate

 Leukotriene C4 Modulation Type Inhibition

Cell System

 Human cervical cancer cell line (Hela)-MRP1

  DT Modulation 3

 Cyclosporine inhibits the transportation of Calcein AM by ABCC1 [9]

Affected Drug/Substrate

 Calcein AM Modulation Type Inhibition

Cell System

 Baby Hamster Kidney fibroblasts-21-MRP1

  Quercetin

            3 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Quercetin inhibits the transportation of Leukotriene C4 by ABCC1 (Ki = 8.1 microM) [8]

Affected Drug/Substrate

 Leukotriene C4 Modulation Type Inhibition

Cell System

 Human cervical cancer cell line (Hela)-MRP1

  DT Modulation 2

 Quercetin inhibits the transportation of Rhodamine 123 by ABCC1 [11]

Affected Drug/Substrate

 Rhodamine 123 Modulation Type Inhibition

Cell System

 Large-cell lung cancer cell line (COR-L23/P)-MRP1

  DT Modulation 3

 Quercetin induces the activity of ABCC1 [12]

Cell System

 Human breast adenocarcinoma cell line (MCF-7)-MRP1

  Verapamil

            2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Verapamil inhibits the transportation of Doxorubicin by ABCC1 (Ki = 13.2 microM) [3]

Affected Drug/Substrate

 Doxorubicin Modulation Type Inhibition

Cell System

 Human 2008/MRP1 ovarian carcinoma cells

  DT Modulation 2

 Verapamil inhibits the activity of ABCC1 [3] , [15] , [16]

  Progesterone

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Progesterone inhibits the transportation of Calcein by ABCC1 [18]

Affected Drug/Substrate

 Calcein Modulation Type Inhibition

Cell System

 Human multidrug resistant lung cancer GLC4/ADR cells

  Rifampicin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Rifampicin inhibits the transportation of Calcein by ABCC1 [19]

Affected Drug/Substrate

 Calcein Modulation Type Inhibition

Cell System

 Human multidrug resistant lung cancer GLC4/ADR cells

  Rifamycin B

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Rifamycin B inhibits the transportation of Calcein by ABCC1 [19]

Affected Drug/Substrate

 Calcein Modulation Type Inhibition

Cell System

 Human multidrug resistant lung cancer GLC4/ADR cells

  Etoposide

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Etoposide inhibits the transportation of Dinitrophenyl-glutathione by ABCC1 [20]

Affected Drug/Substrate

 Dinitrophenyl-glutathione Modulation Type Inhibition

Cell System

 Human multidrug resistant lung cancer GLC4/ADR cells

  Idarubicin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Idarubicin inhibits the transportation of Dinitrophenyl-glutathione by ABCC1 [20]

Affected Drug/Substrate

 Dinitrophenyl-glutathione Modulation Type Inhibition

Cell System

 Human multidrug resistant lung cancer GLC4/ADR cells

  Indocyanine green

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Indocyanine green inhibits the transportation of Dinitrophenyl-glutathione by ABCC1 [20]

Affected Drug/Substrate

 Dinitrophenyl-glutathione Modulation Type Inhibition

Cell System

 Human multidrug resistant lung cancer GLC4/ADR cells

  Tiopronin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Tiopronin inhibits the transportation of Calcein AM by ABCC1 [24]

Affected Drug/Substrate

 Calcein AM Modulation Type Inhibition

  Ofloxacin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Ofloxacin inhibits the transportation of Vincristine by ABCC1 [25]

Affected Drug/Substrate

 Vincristine Modulation Type Inhibition

  Phenobarbital

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Phenobarbital induces the activity of ABCC1 [27]

Cell System

 Human hepatocellular carcinoma cell line (HepG2)-MRP1

  Vinblastine

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Vinblastine induces the activity of ABCC1 [28]

Cell System

 Human breast adenocarcinoma cell line (MCF-7)-MRP1

  Benzbromarone

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Benzbromarone inhibits the activity of ABCC1 [29]

Cell System

 Spodoptera frugiperda (Sf9) cells-MRP1

  Calcitriol

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Calcitriol inhibits the activity of ABCC1 [30]

Cell System

 Human embryonic kidney 293 cells (HEK293)-MRP1

  Methotrexate

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Methotrexate increases the expression of ABCC1 [31]

Regulation Mechanism

 via enhancement of Nuclear factor erythroid 2-related factor 2 (NFE2L2) Transcription Factor Info

Cell System

 Human leukemic cells (CCRFCEM)

  Titanium dioxide

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Titanium dioxide increases the expression of ABCC1 [32]

Regulation Mechanism

 via enhancement of Nuclear receptor subfamily 1 group I member 2 (NR1I2) Transcription Factor Info

Cell System

 Human lung adenocarcinoma cells (A549)

  Decitabine

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Decitabine increases the expression of ABCC1 [33]

  Sulindac

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Sulindac increases the expression of ABCC1 [34]

  Docetaxel

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Docetaxel increases the expression of ABCC1 [35]

  Haloperidol

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Haloperidol inhibits the expression of ABCC1 [36]

  Venlafaxine Hydrochloride

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Venlafaxine Hydrochloride increases the expression of ABCC1 [37]

  Heparin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Heparin affects the activity of ABCC1 [38]

  Cannabidiol

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Cannabidiol inhibits the activity of ABCC1 [39]

  Dronabinol

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Dronabinol inhibits the activity of ABCC1 [39]

  Irinotecan

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Irinotecan inhibits the expression of ABCC1 [40]

  Copper Sulfate

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Copper Sulfate increases the expression of ABCC1 [41]

  Testosterone

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Testosterone increases the expression of ABCC1 [42]

  Aspirin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Aspirin increases the expression of ABCC1 [43]

  Zidovudine

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Zidovudine increases the expression of ABCC1 [45]

  Valproic Acid

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Valproic Acid affects the expression of ABCC1 [46]

  Chloroquine

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Chloroquine inhibits the expression of ABCC1 [47]

  Mebendazole

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Mebendazole inhibits the expression of ABCC1 [48]

  Leflunomide

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Leflunomide increases the expression of ABCC1 [49]

  Methoxsalen

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Methoxsalen increases the expression of ABCC1 [50]

  Doxorubicin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Doxorubicin inhibits the expression of ABCC1 [51]

  Dabrafenib

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Dabrafenib increases the expression of ABCC1 [52]

  Rifampin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Rifampin increases the expression of ABCC1 [53]

  Arsenic Trioxide

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Arsenic Trioxide inhibits the expression of ABCC1 [54]

  Ritonavir

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Ritonavir induces the activity of ABCC1 [55]

  Daunorubicin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Daunorubicin induces the activity of ABCC1 [56] , [57]

  Probenecid

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Probenecid inhibits the activity of ABCC1 [58] , [59]

  Rofecoxib

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Rofecoxib induces the activity of ABCC1 [60]

  Acetaminophen

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Acetaminophen induces the activity of ABCC1 [61]

  Quinine

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Quinine inhibits the activity of ABCC1 [62] , [59]

  Estradiol

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Estradiol induces the activity of ABCC1 [63]

  Ivermectin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Ivermectin inhibits the activity of ABCC1 [64]

  Ouabain

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Ouabain induces the activity of ABCC1 [65] , [66]

  Epirubicin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Epirubicin induces the activity of ABCC1 [67]

  Saquinavir

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Saquinavir induces the activity of ABCC1 [68]

  Disulfiram

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Disulfiram inhibits the activity of ABCC1 [69]

  Budesonide

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Budesonide inhibits the activity of ABCC1 [70]

  Ethanol

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Ethanol induces the activity of ABCC1 [71]

  Lovastatin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Lovastatin inhibits the activity of ABCC1 [72]

  Sulfinpyrazone

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Sulfinpyrazone inhibits the activity of ABCC1 [73] , [74]

  Celecoxib

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Celecoxib inhibits the activity of ABCC1 [75]

  Clotrimazole

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Clotrimazole inhibits the activity of ABCC1 [76]

  Dipyridamole

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Dipyridamole inhibits the activity of ABCC1 [77]

  Menadione

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Menadione induces the activity of ABCC1 [78]

  Trastuzumab

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Trastuzumab inhibits the activity of ABCC1 [79]

  Temozolomide

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Temozolomide induces the activity of ABCC1 [80]

  Bortezomib

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Bortezomib inhibits the expression of ABCC1 [51]

Regulation Mechanism

 via the inhibition of Transcription factor p65 (RELA) Transcription Factor Info

Affected Drug/Substrate

 Doxorubicin Modulation Type Inhibition

Cell System

 Human breast adenocarcinoma cells (MDA-MB-231)

Drug Marketed but not Approved by US FDA

  Formononetin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Formononetin inhibits the expression of ABCC1 [44]

Drug in Phase 4 Trial

  Silymarin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Silymarin inhibits the activity of ABCC1 [22] , [120]

Drug in Phase 3 Trial

  Curcumin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Curcumin inhibits the transportation of Ethacrynic acid glutathione by ABCC1 (IC50 = 15 microM) [2]

Affected Drug/Substrate

 Ethacrynic acid glutathione Modulation Type Inhibition

Cell System

 Spodoptera frugiperda (Sf9) cells-MRP1

  SGX301

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 SGX301 increases the expression of ABCC1 [101]

  Triclosan

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Triclosan increases the expression of ABCC1 [110]

  Epigallocatechin gallate

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Epigallocatechin gallate inhibits the expression of ABCC1 [115]

  Resveratrol

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Resveratrol inhibits the expression of ABCC1 [117]

Drug in Phase 2 Trial

  Genistein

            2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Genistein inhibits the transportation of 2',7'-Bis-(3-carboxy-propyl)-5-(and-6)-carboxyfluorescein (BCPCF) by ABCC1 (IC50 = 80 microM) [1]

Affected Drug/Substrate

 2',7'-Bis-(3-carboxy-propyl)-5-(and-6)-carboxyfluorescein (BCPCF) Modulation Type Inhibition

Cell System

 Human erythrocytes-MRP1

  DT Modulation 2

 Genistein inhibits the transportation of Rhodamine 123 by ABCC1 [11]

Affected Drug/Substrate

 Rhodamine 123 Modulation Type Inhibition

Cell System

 Large-cell lung cancer cell line (COR-L23/P)-MRP1

  Nimustine

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Nimustine increases the expression of ABCC1 [83]

  Bisphenol A

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Bisphenol A increases the expression of ABCC1 [107]

Drug in Phase 1 Trial

  Glutathiol

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Glutathiol increases the activity of ABCC1 [8]

  Naringenin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Naringenin increases the activity of ABCC1 [8]

  Tetradecanoylphorbol Acetate

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Tetradecanoylphorbol Acetate inhibits the expression of ABCC1 [86]

  Eriodictyol

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Eriodictyol inhibits the activity of ABCC1 [89]

  Luteolin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Luteolin inhibits the activity of ABCC1 [89]

  Phenethyl caffeate

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Phenethyl caffeate inhibits the activity of ABCC1 [91]

  Epsilon-viniferin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Epsilon-viniferin inhibits the activity of ABCC1 [92]

  Dihydrotestosterone

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Dihydrotestosterone inhibits the expression of ABCC1 [93]

  Sodium arsenite

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Sodium arsenite increases the expression of ABCC1 [96]

  NS-398

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 NS-398 increases the expression of ABCC1 [97]

  HSDB-3466

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 HSDB-3466 increases the expression of ABCC1 [50]

  Adenosine Triphosphate

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Adenosine Triphosphate affects the activity of ABCC1 [112]

Discontinued Drug

  MK-571

            6 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 MK-571 inhibits the transportation of 2',7'-Bis-(3-carboxy-propyl)-5-(and-6)-carboxyfluorescein (BCPCF) by ABCC1 (IC50 = 3.5 microM) [1]

Affected Drug/Substrate

 2',7'-Bis-(3-carboxy-propyl)-5-(and-6)-carboxyfluorescein (BCPCF) Modulation Type Inhibition

Cell System

 Human erythrocytes-MRP1

  DT Modulation 2

 MK-571 inhibits the transportation of Calcein AM by ABCC1 (IC50 = 5 microM) [2]

Affected Drug/Substrate

 Calcein AM Modulation Type Inhibition

Cell System

 Madin Darby canine kidney strain II (MDCKII) cells-MRP1

  DT Modulation 3

 MK-571 inhibits the transportation of Doxorubicin by ABCC1 (Ki = 134.7 microM) [3]

Affected Drug/Substrate

 Doxorubicin Modulation Type Inhibition

Cell System

 Human 2008/MRP1 ovarian carcinoma cells

  DT Modulation 4

 MK-571 inhibits the transportation of Leukotriene C4 by ABCC1 (IC50 = 0.6 microM) [4]

Affected Drug/Substrate

 Leukotriene C4 Modulation Type Inhibition

Cell System

 Human cervical cancer cell line (Hela)-MRP1

  DT Modulation 5

 MK-571 inhibits the transportation of Calcein AM by ABCC1 [5]

Affected Drug/Substrate

 Calcein AM Modulation Type Inhibition

  DT Modulation 6

 MK-571 inhibits the activity of ABCC1 [3]

  Valspodar

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Valspodar inhibits the transportation of Leukotriene C4 by ABCC1 (Ki = 27 microM) [4]

Affected Drug/Substrate

 Leukotriene C4 Modulation Type Inhibition

Cell System

 Human cervical cancer cell line (Hela)-MRP1

Investigative Drug

  Estrone sulfate

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Estrone sulfate inhibits the transportation of Leukotriene C4 by ABCC1 (Ki = 0.45 microM) [17]

Affected Drug/Substrate

 Leukotriene C4 Modulation Type Inhibition

Cell System

 Human cervical cancer cell line (Hela)-MRP1

  Kaempferol

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Kaempferol inhibits the transportation of Leukotriene C4 by ABCC1 (Ki = 2.4 microM) [8]

Affected Drug/Substrate

 Leukotriene C4 Modulation Type Inhibition

Cell System

 Human cervical cancer cell line (Hela)-MRP1

  Myricetin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Myricetin inhibits the transportation of Leukotriene C4 by ABCC1 (Ki = 13.3 microM) [8]

Affected Drug/Substrate

 Leukotriene C4 Modulation Type Inhibition

Cell System

 Human cervical cancer cell line (Hela)-MRP1

  GF-109203

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 GF-109203 inhibits the transportation of Rhodamine 123 by ABCC1 [26]

Affected Drug/Substrate

 Rhodamine 123 Modulation Type Inhibition

  3,3',4,5'-tetrahydroxystilbene

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 3,3',4,5'-tetrahydroxystilbene inhibits the activity of ABCC1 [92]

  27-hydroxycholesterol

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 27-hydroxycholesterol increases the expression of ABCC1 [114]

  N-ethylmaleimide

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 N-ethylmaleimide affects the activity of ABCC1 [119]

Patented Pharmaceutical Agent

  HSDB-595

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 HSDB-595 inhibits the expression of ABCC1 [98]

  ICG-001

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 ICG-001 inhibits the expression of ABCC1 [104]

Drug Withdrawn

  Rimonabant

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Rimonabant inhibits the transportation of Estradiol 17b-D-glucuronide by ABCC1 [21]

Affected Drug/Substrate

 Estradiol 17b-D-glucuronide Modulation Type Inhibition

Cell System

 Human embryonic kidney 293 cells (HEK293)-MRP1

  Nimesulide

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Nimesulide increases the expression of ABCC1 [97]

Natural Product

  Plant polyphenols

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Plant polyphenols inhibits the transportation of 2,4-dinitrophenyl-S-glutathione by ABCC1 [22]

Affected Drug/Substrate

 2,4-dinitrophenyl-S-glutathione Modulation Type Inhibition

Cell System

 Human embryonic kidney 293 cells (HEK293)-MRP1

  Glycyrrhetinic acid

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Glycyrrhetinic acid inhibits the transportation of Calcein by ABCC1 [23]

Affected Drug/Substrate

 Calcein Modulation Type Inhibition

Cell System

 Multiple drug-resistant human KB carcinoma cell line (KB-C2)-MRP1

  Genistin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Genistin inhibits the transportation of Rhodamine 123 by ABCC1 [11]

Affected Drug/Substrate

 Rhodamine 123 Modulation Type Inhibition

Cell System

 Large-cell lung cancer cell line (COR-L23/P)-MRP1

  Flavone

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Flavone inhibits the activity of ABCC1 [84]

  Taxifolin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Taxifolin inhibits the activity of ABCC1 [84]

  Flavonoids

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Flavonoids inhibits the expression of ABCC1 [85]

  Polyphenols

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Polyphenols inhibits the expression of ABCC1 [85]

  Biochanin A

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Biochanin A inhibits the activity of ABCC1 [87]

  Apigenin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Apigenin inhibits the activity of ABCC1 [89]

  Baicalein

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Baicalein inhibits the activity of ABCC1 [89]

  Diosmetin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Diosmetin inhibits the activity of ABCC1 [89]

  Galangin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Galangin inhibits the activity of ABCC1 [89]

  Robinetin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Robinetin inhibits the activity of ABCC1 [89]

  Gallocatechol

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Gallocatechol affects the activity of ABCC1 [90]

  Tobacco Smoke Pollution

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Tobacco Smoke Pollution inhibits the expression of ABCC1 [108]

Plant Extract

  Plant Extracts

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Plant Extracts inhibits the expression of ABCC1 [85]

  Apple polyphenol extract

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Apple polyphenol extract increases the expression of ABCC1 [94]

Environmental toxicant

  2-tert-butylhydroquinone

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 2-tert-butylhydroquinone increases the expression of ABCC1 [82]

Regulation Mechanism

 via enhancement of Nuclear factor erythroid 2-related factor 2 (NFE2L2) Transcription Factor Info

Cell System

 Human hepatoblastoma cells (HepG2)

  Tetrabromobisphenol A

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Tetrabromobisphenol A inhibits the activity of ABCC1 [99]

  Demethoxycurcumin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Demethoxycurcumin inhibits the activity of ABCC1 [116]

Mycotoxins

  Puromycin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Puromycin increases the expression of ABCC1 [81]

Regulation Mechanism

 via enhancement of Transcription factor SOX-18 (SOX18) Transcription Factor Info

Cell System

 Human induced pluripotent stem cells (iMR90-4)

Acute Toxic Substance

  Mercuric Chloride

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Mercuric Chloride increases the expression of ABCC1 [88]

  Morin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Morin inhibits the activity of ABCC1 [89]

  2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine increases the expression of ABCC1 [95]

  Avermectin B1a

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Avermectin B1a inhibits the activity of ABCC1 [102]

  Paraquat

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Paraquat inhibits the expression of ABCC1 [105]

Carcinogen

  Benzo(a)pyrene

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Benzo(a)pyrene increases the expression of ABCC1 [118]

Pesticide/Insecticide

  Dicrotophos

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Dicrotophos increases the expression of ABCC1 [106]

  Clothianidin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Clothianidin increases the expression of ABCC1 [111]

Health and Environmental Toxicant

  3-methylquercetin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 3-methylquercetin inhibits the activity of ABCC1 [89]

  Butyraldehyde

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Butyraldehyde inhibits the expression of ABCC1 [103]

  Perfluorooctane sulfonic acid

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Perfluorooctane sulfonic acid inhibits the expression of ABCC1 [113]

Herbicide

  Monomethylarsonic acid

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Monomethylarsonic acid affects the expression of ABCC1 [100]

Nanoparticle

  Silver nanoparticle

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Silver nanoparticle increases the expression of ABCC1 [109]
References
1 Modulation of MRP1 protein transport by plant, and synthetically modified flavonoids. Life Sci. 2005 Aug 26;77(15):1879-91.
2 Interplay between MRP inhibition and metabolism of MRP inhibitors: the case of curcumin. Chem Res Toxicol. 2003 Dec;16(12):1642-51.
3 Modulation of multidrug resistance protein 1 (MRP1/ABCC1)-mediated multidrug resistance by bivalent apigenin homodimers and their derivatives. J Med Chem. 2009 Sep 10;52(17):5311-22.
4 The MRP gene encodes an ATP-dependent export pump for leukotriene C4 and structurally related conjugates. J Biol Chem. 1994 Nov 11;269(45):27807-10.
5 New Inhibitors of Breast Cancer Resistance Protein (ABCG2) Containing a 2,4-Disubstituted Pyridopyrimidine Scaffold. J Med Chem. 2018 Apr 26;61(8):3389-3408.
6 The sulphonylurea glibenclamide inhibits multidrug resistance protein (MRP1) activity in human lung cancer cells. Br J Pharmacol. 2001 Feb;132(3):778-84.
7 Transport of antimony salts by Arabidopsis thaliana protoplasts over-expressing the human multidrug resistance-associated protein 1 (MRP1/ABCC1). FEBS Lett. 2006 Dec 22;580(30):6891-7.
8 Modulation of multidrug resistance protein 1 (MRP1/ABCC1) transport and atpase activities by interaction with dietary flavonoids. Mol Pharmacol. 2001 May;59(5):1171-80.
9 2-Indolylmethylenebenzofuranones as first effective inhibitors of ABCC2. Eur J Med Chem. 2016 Oct 21;122:408-418.
10 Cytotoxic effects of tanshinones from Salvia miltiorrhiza on doxorubicin-resistant human liver cancer cells. J Nat Prod. 2010 May 28;73(5):854-9.
11 Acceleration of MRP-associated efflux of rhodamine 123 by genistein and related compounds. Br J Cancer. 1996 Dec;74(12):1949-54.
12 Influence of redox-active compounds and PXR-activators on human MRP1 and MRP2 gene expression. Toxicology. 2002 Feb 28;171(2-3):137-46.
13 Multidrug-resistance P-glycoprotein (MDR1) secretes platelet-activating factor. Biochem J. 2001 Aug 1;357(Pt 3):859-65.
14 P-glycoprotein efflux pump expression and activity in Calu-3 cells. J Pharm Sci. 2001 May;90(5):647-58.
15 Modulation of sensitivity to doxorubicin by the histone deacetylase inhibitor sodium butyrate in breast cancer cells. Int J Oncol. 2005 Jun;26(6):1569-74.
16 Comparative study of the importance of multidrug resistance-associated protein 1 and P-glycoprotein to drug sensitivity in immortalized mouse embryonic fibroblasts. Mol Cancer Ther. 2002 Oct;1(12):1105-14.
17 Glutathione stimulates sulfated estrogen transport by multidrug resistance protein 1. J Biol Chem. 2001 Mar 2;276(9):6404-11.
18 Reversal of MRP-mediated multidrug resistance in human lung cancer cells by the antiprogestatin drug RU486. Biochem Biophys Res Commun. 1999 May 19;258(3):513-8.
19 Inhibition of multidrug resistance-associated protein (MRP) activity by rifampicin in human multidrug-resistant lung tumor cells. Cancer Lett. 1999 May 3;139(1):97-104.
20 Anthracyclines modulate multidrug resistance protein (MRP) mediated organic anion transport. Biochim Biophys Acta. 1997 May 22;1326(1):12-22.
21 Cannabinoid type 1 receptor antagonists modulate transport activity of multidrug resistance-associated proteins MRP1, MRP2, MRP3, and MRP4. Drug Metab Dispos. 2011 Jul;39(7):1294-302.
22 Modulatory effects of plant phenols on human multidrug-resistance proteins 1, 4 and 5 (ABCC1, 4 and 5). FEBS J. 2005 Sep;272(18):4725-40.
23 Inhibition of P-glycoprotein and multidrug resistance protein 1 by dietary phytochemicals. Cancer Chemother Pharmacol. 2008 Oct;62(5):867-73.
24 Collateral sensitivity of multidrug-resistant cells to the orphan drug tiopronin. J Med Chem. 2011 Jul 28;54(14):4987-97.
25 Interactions of ofloxacin and erythromycin with the multidrug resistance protein (MRP) in MRP-overexpressing human leukemia cells. Antimicrob Agents Chemother. 2000 Jun;44(6):1697-700.
26 The specific bisindolylmaleimide PKC-inhibitor GF 109203X efficiently modulates MRP-associated multiple drug resistance. Biochem Biophys Res Commun. 1995 Jan 5;206(1):119-26.
27 cDNA cloning and inducible expression of human multidrug resistance associated protein 3 (MRP3). FEBS Lett. 1998 Aug 14;433(1-2):149-52.
28 Up-regulation of transporters of the MRP family by drugs and toxins. Toxicol Lett. 2001 Mar 31;120(1-3):51-7.
29 Molecular docking studies and in vitro screening of new dihydropyridine derivatives as human MRP1 inhibitors. Bioorg Med Chem. 2011 May 15;19(10):3249-54.
30 Calcitriol and Calcipotriol Modulate Transport Activity of ABC Transporters and Exhibit Selective Cytotoxicity in MRP1-overexpressing Cells. Drug Metab Dispos. 2018 Dec;46(12):1856-1866.
31 Iron protects childhood acute lymphoblastic leukemia cells from methotrexate cytotoxicity. Cancer Med. 2020 May;9(10):3537-3550.; 2020 May;9(10):3537-3550.
32 Involvement of ABC transporters in the detoxification of non-substrate nanoparticles in lung and cervical cancer cells. Toxicology. 2021 May 15;455:152762.
33 Methylation-dependent silencing of the reduced folate carrier gene in inherently methotrexate-resistant human breast cancer cells. J Biol Chem. 2001 Oct 26;276(43):39990-40000.
34 Induction of multidrug resistance proteins MRP1 and MRP3 and gamma-glutamylcysteine synthetase gene expression by nonsteroidal anti-inflammatory drugs in human colon cancer cells. Biochem Biophys Res Commun. 2002 Feb 8;290(5):1427-33.
35 Enhanced in vitro invasiveness and drug resistance with altered gene expression patterns in a human lung carcinoma cell line after pulse selection with anticancer drugs. Int J Cancer. 2004 Sep 10;111(4):484-93.
36 [Reversal effect of haloperidol on doxorubicin resistance and chloride channel inhibition in erythroleukemic cell K562/Dox]. Zhonghua Zhong Liu Za Zhi. 2005 Feb;27(2):81-5.
37 Venlafaxine induces P-glycoprotein in human Caco-2 cells. Hum Psychopharmacol. 2007 Jan;22(1):49-53.
38 Modulatory effects of heparin on cellular accumulation and cytotoxicity of doxorubicin in MRP1-overexpressing HL60/doxo cells. Anticancer Res. 2007 Jan-Feb;27(1A):351-5.
39 Interaction of plant cannabinoids with the multidrug transporter ABCC1 (MRP1). Eur J Pharmacol. 2008 Sep 4;591(1-3):128-31.
40 Clinical determinants of response to irinotecan-based therapy derived from cell line models. Clin Cancer Res. 2008 Oct 15;14(20):6647-55.
41 Physiological and toxicological transcriptome changes in HepG2 cells exposed to copper. Physiol Genomics. 2009 Aug 7;38(3):386-401.
42 Effects of 1alpha,25 dihydroxyvitamin D3 and testosterone on miRNA and mRNA expression in LNCaP cells. Mol Cancer. 2011 May 18;10:58.
43 Prolonged use of aspirin alters human and rat intestinal cells and thereby limits the absorption of clopidogrel. Clin Pharmacol Ther. 2011 Oct;90(4):612-9.
44 Formononetin potentiates epirubicin-induced apoptosis via ROS production in HeLa cells in vitro. Chem Biol Interact. 2013 Oct 5;205(3):188-97.
45 Differential gene expression in human hepatocyte cell lines exposed to the antiretroviral agent zidovudine. Arch Toxicol. 2014 Mar;88(3):609-23.
46 Gene Expression Regulation and Pathway Analysis After Valproic Acid and Carbamazepine Exposure in a Human Embryonic Stem Cell-Based Neurodevelopmental Toxicity Assay. Toxicol Sci. 2015 Aug;146(2):311-20.
47 Autophagy inhibition upregulates CD4+ tumor infiltrating lymphocyte expression via miR-155 regulation and TRAIL activation. Mol Oncol. 2016 Dec;10(10):1516-1531.
48 Mebendazole, an antiparasitic drug, inhibits drug transporters expression in preclinical model of gastric peritoneal carcinomatosis. Toxicol In Vitro. 2017 Sep;43:87-91.
49 Endoplasmic reticulum stress and MAPK signaling pathway activation underlie leflunomide-induced toxicity in HepG2 Cells. Toxicology. 2017 Dec 1;392:11-21.
50 ABC-transporter blockage mediated by xanthotoxin and bergapten is the major pathway for chemosensitization of multidrug-resistant cancer cells. Toxicol Appl Pharmacol. 2017 Dec 15;337:22-29.
51 Nuclear factor-KappaB signaling inhibitors revert multidrug-resistance in breast cancer cells. Chem Biol Interact. 2021 May 1;340:109450.
52 Dabrafenib inhibits ABCG2 and cytochrome P450 isoenzymes; potential implications for combination anticancer therapy. Toxicol Appl Pharmacol. 2022 Jan 1;434:115797.
53 Isocitrate dehydrogenase 2 inhibitor enasidenib synergizes daunorubicin cytotoxicity by targeting aldo-keto reductase 1C3 and ATP-binding cassette transporters. Arch Toxicol. 2022 Dec;96(12):3265-3277.
54 Effects of Proanthocyanidins on Arsenic Methylation Metabolism and Efflux in Human Hepatocytes L-02. Biomed Res Int. 2019 Jul 4;2019:3924581.
55 Ritonavir induces P-glycoprotein expression, multidrug resistance-associated protein (MRP1) expression, and drug transporter-mediated activity in a human intestinal cell line. J Pharm Sci. 2001 Nov;90(11):1829-37.
56 Vinblastine and sulfinpyrazone export by the multidrug resistance protein MRP2 is associated with glutathione export. Br J Cancer. 2000 Aug;83(3):375-83.
57 Inhibitory effect of the reversal agents V-104, GF120918 and Pluronic L61 on MDR1 Pgp-, MRP1- and MRP2-mediated transport. Br J Cancer. 2000 Aug;83(3):366-74.
58 In vivo and in vitro modulation of MDR molecules in murine thymocytes. Int Immunopharmacol. 2006 Feb;6(2):204-15.
59 Multidrug resistance-associated protein-1 functional activity in Calu-3 cells. J Pharmacol Exp Ther. 2001 Sep;298(3):1199-205.
60 Rofecoxib augments anticancer effects by reversing intrinsic multidrug resistance gene expression in BGC-823 gastric cancer cells. J Dig Dis. 2010 Feb;11(1):34-42.
61 Induction of Mrp3 and Mrp4 transporters during acetaminophen hepatotoxicity is dependent on Nrf2. Toxicol Appl Pharmacol. 2008 Jan 1;226(1):74-83.
62 Carrier mediated transport of chlorpheniramine and chlorcyclizine across bovine olfactory mucosa: implications on nose-to-brain transport. J Pharm Sci. 2005 Mar;94(3):613-24.
63 Estradiol induces export of sphingosine 1-phosphate from breast cancer cells via ABCC1 and ABCG2. J Biol Chem. 2010 Apr 2;285(14):10477-86.
64 Interaction of ivermectin with multidrug resistance proteins (MRP1, 2 and 3). Chem Biol Interact. 2006 Feb 25;159(3):169-79.
65 Modulation of multidrug resistance protein (MRP1/ABCC1) expression: a novel physiological role for ouabain. Cell Biol Toxicol. 2007 Nov;23(6):421-7.
66 Reduced glutathione protect cells from ouabain toxicity. Biochim Biophys Acta. 2001 Jun 15;1526(3):293-300.
67 Induction of broad drug resistance in small cell lung cancer cells and its reversal by paclitaxel. Int J Cancer. 1998 May 29;76(5):702-8.
68 Direct evidence that saquinavir is transported by multidrug resistance-associated protein (MRP1) and canalicular multispecific organic anion transporter (MRP2). Antimicrob Agents Chemother. 2002 Nov;46(11):3456-62.
69 The molecular basis of the action of disulfiram as a modulator of the multidrug resistance-linked ATP binding cassette transporters MDR1 (ABCB1) and MRP1 (ABCC1). Mol Pharmacol. 2004 Mar;65(3):675-84.
70 Budesonide reduces multidrug resistance-associated protein 1 expression in an airway epithelial cell line (Calu-1). Eur J Pharmacol. 2002 Feb 15;437(1-2):9-17.
71 Effect of alcohol on drug efflux protein and drug metabolic enzymes in U937 macrophages. Alcohol Clin Exp Res. 2011 Jan;35(1):132-9.
72 Inhibition of ABC transporters abolishes antimony resistance in Leishmania Infection. Antimicrob Agents Chemother. 2008 Mar;52(3):1080-93.
73 Functional expression of the multidrug resistance protein 1 in microglia. J Pharmacol Exp Ther. 2003 Oct;307(1):282-90.
74 The human multidrug resistance protein MRP1 translocates sphingolipid analogs across the plasma membrane. J Cell Sci. 1999 Feb;112 ( Pt 3):415-22.
75 Cyclooxygenase-independent down-regulation of multidrug resistance-associated protein-1 expression by celecoxib in human lung cancer cells. Mol Cancer Ther. 2005 Sep;4(9):1358-63.
76 Effects of clotrimazole on transport mediated by multidrug resistance associated protein 1 (MRP1) in human erythrocytes and tumour cells. Eur J Biochem. 2001 Dec;268(24):6569-77.
77 Quantitative immunoassay to measure plasma and intracellular atazanavir levels: analysis of drug accumulation in cultured T cells. Antimicrob Agents Chemother. 2007 Feb;51(2):405-11.
78 Expression of multidrug resistance protein/GS-X pump and gamma-glutamylcysteine synthetase genes is regulated by oxidative stress. J Biol Chem. 1998 Nov 20;273(47):31075-85.
79 Effect of trastuzumab in combination with IFN alpha-2b on HER2 and- MRP1 of ACHN. J Huazhong Univ Sci Technolog Med Sci. 2005;25(3):326-8.
80 miR-1268a regulates ABCC1 expression to mediate temozolomide resistance in glioblastoma. J Neurooncol. 2018 Jul;138(3):499-508.
81 The maturation of iPS cell-derived brain microvascular endothelial cells by inducible-SOX18 expression. Fluids Barriers CNS. 2023 Feb 2;20(1):10.; 2023 Feb 2;20(1):10.
82 Nrf2-dependent and -independent induction of ABC transporters ABCC1, ABCC2, and ABCG2 in HepG2 cells under oxidative stress. J Exp Ther Oncol. 2007;6(4):335-48.
83 Transient induction of the MRP/GS-X pump and gamma-glutamylcysteine synthetase by 1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl)-3- nitrosourea in human glioma cells. Cancer Res. 1997 Dec 1;57(23):5292-9.
84 Structural requirements for the flavonoid-mediated modulation of glutathione S-transferase P1-1 and GS-X pump activity in MCF7 breast cancer cells. Biochem Pharmacol. 2004 Apr 15;67(8):1607-17.
85 Epicatechin and a cocoa polyphenolic extract modulate gene expression in human Caco-2 cells. J Nutr. 2004 Oct;134(10):2509-16.
86 Differentiation and drug resistance relationships in leukemia cells. J Cell Biochem. 2005 Jan 1;94(1):98-108.
87 Metabolic O-demethylation does not alter the influence of isoflavones on the biophysical properties of membranes and MRP1-like protein transport activity. Arch Biochem Biophys. 2005 Jan 15;433(2):428-34.
88 Mercury induces multidrug resistance-associated protein gene through p38 mitogen-activated protein kinase. Toxicol Lett. 2005 Jan 15;155(1):143-50.
89 Quantitative structure activity relationship studies on the flavonoid mediated inhibition of multidrug resistance proteins 1 and 2. Biochem Pharmacol. 2005 Feb 15;69(4):699-708.
90 In vitro search for synergy between flavonoids and epirubicin on multidrug-resistant cancer cells. In Vivo. 2005 Mar-Apr;19(2):367-74.
91 Inhibition of multidrug resistance proteins MRP1 and MRP2 by a series of alpha,beta-unsaturated carbonyl compounds. Biochem Pharmacol. 2005 Jun 15;69(12):1879-90.
92 Resveratrol oligomers are potent MRP1 transport inhibitors. Anticancer Res. 2006 May-Jun;26(3A):2081-4.
93 Androgen induces expression of the multidrug resistance protein gene MRP4 in prostate cancer cells. Prostate Cancer Prostatic Dis. 2007;10(1):39-45.
94 Apple polyphenols modulate expression of selected genes related to toxicological defence and stress response in human colon adenoma cells. Int J Cancer. 2008 Jun 15;122(12):2647-55.
95 ABCG2/BCRP decreases the transfer of a food-born chemical carcinogen, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in perfused term human placenta. Toxicol Appl Pharmacol. 2008 Oct 15;232(2):210-7.
96 Arsenic-specific stem cell selection during malignant transformation. J Natl Cancer Inst. 2010 May 5;102(9):638-49.
97 COX-2 inhibitors block chemotherapeutic agent-induced apoptosis prior to commitment in hematopoietic cancer cells. Biochem Pharmacol. 2011 Nov 15;82(10):1277-90.
98 Diallyl sulfide, diallyl disulfide and diallyl trisulfide affect drug resistant gene expression in colo 205 human colon cancer cells in vitro and in vivo. Phytomedicine. 2012 May 15;19(7):625-30.
99 Endocrine disruptors differentially target ATP-binding cassette transporters in the blood-testis barrier and affect Leydig cell testosterone secretion in vitro. Toxicol Sci. 2013 Dec;136(2):382-91.
100 Methylarsonous acid causes oxidative DNA damage in cells independent of the ability to biomethylate inorganic arsenic. Arch Toxicol. 2014 Feb;88(2):249-61.
101 Single pre-treatment with hypericin, a St. John's wort secondary metabolite, attenuates cisplatin- and mitoxantrone-induced cell death in A2780, A2780cis and HL-60 cells. Toxicol In Vitro. 2014 Oct;28(7):1259-73.
102 Characterization of multidrug transporter-mediated efflux of avermectins in human and mouse neuroblastoma cell lines. Toxicol Lett. 2015 Jun 15;235(3):189-98.
103 Integrated analysis of microRNA and mRNA expression profiles highlights aldehyde-induced inflammatory responses in cells relevant for lung toxicity. Toxicology. 2015 Aug 6;334:111-21.
104 Altering cancer transcriptomes using epigenomic inhibitors. Epigenetics Chromatin. 2015 Feb 24;8:9.
105 Cycloartenyl Ferulate Inhibits Paraquat-Induced Apoptosis in HK-2 Cells With the Involvement of ABCC1. J Cell Biochem. 2016 Apr;117(4):872-80.
106 Molecular mechanisms of discrotophos-induced toxicity in HepG2 cells: The role of CSA in oxidative stress. Food Chem Toxicol. 2017 May;103:253-260.
107 Bisphenol A induces DSB-ATM-p53 signaling leading to cell cycle arrest, senescence, autophagy, stress response, and estrogen release in human fetal lung fibroblasts. Arch Toxicol. 2018 Apr;92(4):1453-1469.
108 Comparative biological impacts of an aerosol from carbon-heated tobacco and smoke from cigarettes on human respiratory epithelial cultures: A systems toxicology assessment. Food Chem Toxicol. 2018 May;115:109-126.
109 RNA-sequencing reveals long-term effects of silver nanoparticles on human lung cells. Sci Rep. 2018 Apr 27;8(1):6668.
110 Triclosan treatment decreased the antitumor effect of sorafenib on hepatocellular carcinoma cells. Onco Targets Ther. 2018 May 18;11:2945-2954.
111 Growth and neurite stimulating effects of the neonicotinoid pesticide clothianidin on human neuroblastoma SH-SY5Y cells. Toxicol Appl Pharmacol. 2019 Nov 15;383:114777.
112 Human multidrug resistance protein 4 (MRP4) is a cellular efflux transporter for paracetamol glutathione and cysteine conjugates. Arch Toxicol. 2020 Sep;94(9):3027-3032.
113 An assessment of serum-dependent impacts on intracellular accumulation and genomic response of per- and polyfluoroalkyl substances in a placental trophoblast model. Environ Toxicol. 2020 Dec;35(12):1395-1405.
114 27-Hydroxycholesterol is a specific factor in the neoplastic microenvironment of HCC that causes MDR via GRP75 regulation of the redox balance and metabolic reprogramming. Cell Biol Toxicol. 2022 Apr;38(2):311-324.
115 Low dose epigallocatechin-3-gallate revives doxorubicin responsiveness by a redox-sensitive pathway in A549 lung adenocarcinoma cells. J Biochem Mol Toxicol. 2022 Apr;36(4):e22999.
116 Curcuminoids purified from turmeric powder modulate the function of human multidrug resistance protein 1 (ABCC1). Cancer Chemother Pharmacol. 2006 Feb;57(3):376-88.
117 Resveratrol-mediated reversal of doxorubicin resistance in acute myeloid leukemia cells via downregulation of MRP1 expression. Biochem Biophys Res Commun. 2010 Apr 23;395(1):104-10.
118 New insights into BaP-induced toxicity: role of major metabolites in transcriptomics and contribution to hepatocarcinogenesis. Arch Toxicol. 2016 Jun;90(6):1449-58.
119 Expression of the multidrug resistance-associated protein (MRP) and chemoresistance of human non-small-cell lung cancer cells. Int J Cancer. 1997 Sep 26;73(1):84-93.
120 Effect of flavonoids on MRP1-mediated transport in Panc-1 cells. J Pharm Sci. 2003 Feb;92(2):250-7.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.